Search research articles
Contact Us
Filters
Showing results (111-120 of 119) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 119 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2021
Predictors of <sup>18</sup>F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
Esther Mena, Steven P Rowe, Joanna H Shih, et al.
Blood
|
February 1, 2012
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation
Nancy M Hardy, Vicki Fellowes, Jeremy J Rose, et al.
Oncotarget
|
March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors
Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 7, 2025
Artificial intelligence-based lesion characterization and outcome prediction of prostate cancer on [<sup>18</sup>F]DCFPyL PSMA imaging
Linmei Zhao, Maliha R Imami, Yuli Wang, et al.
Academic Radiology
|
January 23, 2024
Deep Learning-Based Detection and Classification of Bone Lesions on Staging Computed Tomography in Prostate Cancer: A Development Study
Mason J Belue, Stephanie A Harmon, Dong Yang, et al.
JAMA Oncology
|
September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial
Dickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Nature Medicine
|
April 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Patrick J Grohar, Rachel Heise, Mary Frances Wedekind, et al.
The New England Journal of Medicine
|
June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 119) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 119 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2021
Predictors of <sup>18</sup>F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
Esther Mena, Steven P Rowe, Joanna H Shih, et al.
Blood
|
February 1, 2012
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation
Nancy M Hardy, Vicki Fellowes, Jeremy J Rose, et al.
Oncotarget
|
March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors
Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 7, 2025
Artificial intelligence-based lesion characterization and outcome prediction of prostate cancer on [<sup>18</sup>F]DCFPyL PSMA imaging
Linmei Zhao, Maliha R Imami, Yuli Wang, et al.
Academic Radiology
|
January 23, 2024
Deep Learning-Based Detection and Classification of Bone Lesions on Staging Computed Tomography in Prostate Cancer: A Development Study
Mason J Belue, Stephanie A Harmon, Dong Yang, et al.
JAMA Oncology
|
September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial
Dickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Nature Medicine
|
April 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Patrick J Grohar, Rachel Heise, Mary Frances Wedekind, et al.
The New England Journal of Medicine
|
June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Page
of 12